654.90
+14.80
+(2.31%)
At close: 3:30:01 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
12,465,503
11,508,368
10,434,464
11,400,492
9,001,590
Cost of Revenue
4,030,417
4,075,544
4,168,439
3,840,982
2,707,689
Gross Profit
8,435,086
7,432,824
6,266,025
7,559,510
6,293,901
Operating Expense
6,467,152
6,093,947
6,311,992
6,301,200
5,100,853
Operating Income
1,967,934
1,338,877
-45,967
1,258,310
1,193,048
Net Non Operating Interest Income Expense
-838,606
-904,253
-568,914
-389,225
-184,312
Pretax Income
1,347,734
543,406
-382,794
1,022,648
1,950,520
Tax Provision
464,807
223,855
-73,066
416,827
488,483
Net Income Common Stockholders
882,867
318,742
-325,332
606,623
1,477,803
Diluted NI Available to Com Stockholders
882,867
318,742
-325,332
606,623
1,477,803
Basic EPS
9.37
3.67
-3.75
7.26
18.13
Diluted EPS
9.37
3.67
-3.75
7.26
18.13
Basic Average Shares
94,795.90
86,801.90
86,801.90
83,535.73
81,526.90
Diluted Average Shares
94,795.90
86,801.90
86,801.90
83,535.73
81,526.90
Rent Expense Supplemental
--
12,536
10,095
11,594
14,606
Total Expenses
10,497,569
10,169,491
10,480,431
10,142,182
7,808,542
Net Income from Continuing & Discontinued Operation
882,868
318,742
-325,332
606,623
1,477,804
Normalized Income
870,070.89
305,068.20
-316,694.60
594,256.80
926,926.40
Interest Income
--
13,841
17,607
20,666
34,375
Interest Expense
771,642
837,289
562,547
409,338
217,071
Net Interest Income
-838,606
-904,253
-568,914
-389,225
-184,312
EBIT
2,119,376
1,380,695
179,753
1,431,986
2,167,591
EBITDA
3,227,624
2,459,394
1,134,743
2,230,005
2,707,358
Reconciled Cost of Revenue
4,030,417
4,075,544
4,168,439
3,840,982
2,707,689
Reconciled Depreciation
1,108,248
1,078,699
954,990
798,019
539,766
Net Income from Continuing Operation Net Minority Interest
882,868
318,742
-325,332
606,623
1,477,804
Total Unusual Items Excluding Goodwill
19,534
19,534
-10,675
17,666
734,932
Total Unusual Items
19,534
19,534
-10,675
17,666
734,932
Normalized EBITDA
3,208,090
2,439,860
1,145,418
2,212,339
1,972,426
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
6,736.89
5,860.20
-2,037.60
5,299.80
184,054.40
3/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KABRADG.BO Kabra Drugs Limited
11.08
0.00%
INNPF InnoCan Pharma Corporation
0.1400
0.00%
EVT.VI Evotec SE
5.90
+2.15%
82P.BE Pacira BioSciences Inc
21.80
0.00%
000250.KQ Sam Chun Dang Pharm. Co., Ltd
156,300.00
+1.49%
CNTC.TA Cannabotech LTD
412.00
+1.01%
TEVJF Teva Pharmaceutical Industries Limited
13.73
0.00%
PGHL.BO Procter & Gamble Health Limited
5,220.50
+1.03%
N4P.L N4 Pharma Plc
0.4000
+6.67%
EOF.AX Ecofibre Limited
0.0220
0.00%